Challenges and Opportunities in Using Residual Newborn Screening Samples for Translational Research

Loading edition detail...

Preparing this view.

Challenges and Opportunities in Using Residual Newborn Screening Samples for Translational Research

Institute of Medicine, Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, Adam C. Berger, Steve Olson

Bookitis Pick

Challenges and Opportunities in Using Residual Newborn Screeni...Institute of Medicine, Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, Adam C. Berger, Steve Olson

Institute of Medicine, Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, Adam C. Berger, Steve OlsonPublished 20102 title views

"Newborn screening samples are used to test more than 4 million infants each year for life-threatening diseases that are treatable if found at birth. These specimens also represent a potentially invaluable resource for public health and biomedical research. The IOM held a workshop to examine issues surrounding the use of residual specimens for translational research."

Main catalog entry More like this

Publisher	National Academies Press
Search language	english
ISBN_13	978-0-309-15955-5 primary

Other editions of this title

Publication-specific alternatives linked to the same work.